Cargando…

Significance of men’s health in long-term survivors of allogeneic stem cell transplantation

Detalles Bibliográficos
Autores principales:	Schneidewind, Laila, Neumann, Thomas, Peters, Nandette, Kranz, Jennifer, Probst, Kai A., Heidel, Florian H., Hakenberg, Oliver W., Krüger, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200626/ https://www.ncbi.nlm.nih.gov/pubmed/35338338 http://dx.doi.org/10.1038/s41409-022-01638-1

Ejemplares similares

Significance of BK Polyomavirus in Long-Term Survivors after Adult Allogeneic Stem Cell Transplantation
por: Neumann, Thomas, et al.
Publicado: (2021)

Behandlungssituation der Fournier-Gangrän an deutschen Universitätskliniken – eine nationale Umfrage zur Deskription aktueller Standards und resultierende Implikationen zur Planung einer Registerstudie
por: Kranz, Jennifer, et al.
Publicado: (2021)

Targeting IL‐11 in the treatment of BK virus‐associated haemorrhagic cystitis—A promising new approach
por: Schneidewind, Laila, et al.
Publicado: (2020)

Welchen Anteil hat die Infektiologie am Fachgebiet Urologie?: Ein Pilotprojekt, zur Hervorhebung der Antibiotic-Stewardship-Bedeutung
por: Schneidewind, Laila, et al.
Publicado: (2022)

Clinical course and end-of-life care in patients who have died after allogeneic stem cell transplantation
por: Busemann, Christoph, et al.
Publicado: (2017)

Reduction of Perioperative Antibiotic Prophylaxis in Open Radical Cystectomy with Ileal Conduit Is Feasible: Results of a Prospective Clinical Trial
por: Schneidewind, Laila, et al.
Publicado: (2022)

Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
por: Vinci, Luca, et al.
Publicado: (2023)

Cerebral toxoplasmosis after allogeneic hematopoietic stem cell transplantation diagnosed by megagenomic analysis
por: Shen, Kai, et al.
Publicado: (2019)

Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival
por: Schneidewind, Laila, et al.
Publicado: (2023)

Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant
por: Shipton, Michael J., et al.
Publicado: (2022)

Soll die asymptomatische Bakteriurie bei Immunsupprimierten antibiotisch therapiert werden?: Ein Rapid Review
por: Stangl, Fabian P., et al.
Publicado: (2023)

First allogeneic hematopoietic stem cell transplantation in RASGRP1 deficiency: long-term follow-up
por: Kuskonmaz, Baris, et al.
Publicado: (2022)

Allogeneic stem cell transplantation for mantle cell lymphoma—update of the prospective trials of the East German Study Group Hematology/Oncology (OSHO#60 and #74)
por: Krüger, William H., et al.
Publicado: (2021)

COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome
por: Lupo-Stanghellini, Maria Teresa, et al.
Publicado: (2021)

Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
por: Sora, Federica, et al.
Publicado: (2022)

Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning
por: Morsink, L. M., et al.
Publicado: (2022)

Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
por: Zhao, Chenchen, et al.
Publicado: (2022)

Alveolar levels of immuno-inflammatory mediators in diffuse alveolar hemorrhage after allogeneic transplant
por: Vande Vusse, Lisa K., et al.
Publicado: (2018)

Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation
por: Mascarenhas, Kristen, et al.
Publicado: (2019)

Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection
por: Christopeit, Maximilian, et al.
Publicado: (2021)

Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia
por: Zhang, Bing-Lei, et al.
Publicado: (2019)

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
por: Pophali, Prateek, et al.
Publicado: (2020)

A case of lupus miliaris disseminatus faciei after allogeneic hematopoietic stem cell transplantation
por: Zhang, Si, et al.
Publicado: (2019)

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
por: Joshi, Maansi, et al.
Publicado: (2021)

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
por: Sellner, Leopold, et al.
Publicado: (2020)

Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19
por: Niederwieser, Christian, et al.
Publicado: (2022)

Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia
por: Baranwal, Anmol, et al.
Publicado: (2022)

Cure of intravascular NK/T-cell lymphoma of the central nervous system by allogeneic hematopoietic cell transplantation
por: Meissner, Julia, et al.
Publicado: (2022)

Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma
por: Yang, Fan, et al.
Publicado: (2022)

Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
por: Mamez, Anne-Claire, et al.
Publicado: (2021)

CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation
por: Calderin Sollet, Zuleika, et al.
Publicado: (2023)

COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
por: Niu, Alex, et al.
Publicado: (2020)

Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative
por: Anthias, Chloe, et al.
Publicado: (2020)

The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma
por: Duraković, Nadira, et al.
Publicado: (2021)

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
por: Pabon, Cindy M., et al.
Publicado: (2021)

Immunoglobulin and granulocyte-colony stimulating factor affecting infection and hematopoietic reconstruction in allogeneic hematopoietic stem cell transplantation
por: Ma, Le, et al.
Publicado: (2023)

Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia
por: Hassan, Mona Ali, et al.
Publicado: (2023)

Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experience
por: Mediwake, Heshani, et al.
Publicado: (2017)

Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma
por: Yang, Luxin, et al.
Publicado: (2018)

High EASIX score is an independent predictor of non-relapse mortality in patients with CMML undergoing allogeneic stem cell transplant
por: Baranwal, Anmol, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8br22jakrmjlskelapgig7qst5